Predicted Impact of Recent Patent Foramen Ovale Closure Trials on Management of Cryptogenic Stroke

Background: The indication for percutaneous closure of patent foramen ovale (PFO) has recently changed, following evidence that closure is superior to medical treatment alone in preventing recurrent stroke in cryptogenic stroke patients aged ≤60 years. We aimed to determine the impact of updated criteria on the management of stroke or transient ischemic attack (TIA) at our institution.

Source: Heart, Lung and Circulation - June 23, 2019 Category: Cardiology Authors: P. Trevella, L. Sanders, D. Jin, J. Gutman, MacA. Isaac, S. Palmer Tags: 667 Source Type: research